Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	$ 39,674	$ 73,800	$ 182,464
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	76,933	47,728	47,418
Deferred tax expense (benefit)	14,777	(14,991)	(4,597)
Equity-based compensation expense	8,134	8,518	5,589
Employee benefit plans	16,897	15,011	14,160
Change in working capital, net	(86,012)	(5,304)	1,768
Change in taxes receivable, net	354	93,754	(101,343)
Excess tax benefits from equity-based payment arrangements	(885)	(855)	(64)
Change in non-current accrued taxes	2,453	(4,271)	73,487
Funding of qualified pension plans	(12,498)	(25,100)
Change in restricted cash, net	4,160
Other, net	4,408	(2,699)	(368)
Net cash (used in) provided by operating activities	68,395	185,591	224,764
CASH FLOWS FROM INVESTING ACTIVITIES
Change in short-term investments, net	71,094	61,926	(177,126)
Additions to plant and equipment	(134,069)	(46,086)	(19,328)
Proceeds from sale of assets	12,826
Net cash used for investing activities	(50,149)	(227,938)	(196,387)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of Cellu Tissue debt	(15,595)	(304,667)
Deferred loan fees	(638)	(1,313)	(1,232)
Purchase of treasury stock	(11,350)
Excess tax benefits from equity-based payment arrangements	885	855	64
Payment of employee restricted stock tax withholdings	(2,400)	(3,470)
Other, net	2	(454)	(12)
Net cash (used for) provided by financing activities	(29,096)	58,451	(28,771)
Effect of exchange rate changes	361
(Decrease) increase in cash	(10,489)	16,104	(394)
Cash at beginning of period	18,928	2,824	3,218
Cash at end of period	8,439	18,928	2,824
Issuer
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	41,724
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	45,439
Deferred tax expense (benefit)	7,264
Equity-based compensation expense	8,134
Employee benefit plans	16,897
Change in working capital, net	(133,142)
Change in taxes receivable, net	(1,368)
Excess tax benefits from equity-based payment arrangements	(885)
Change in non-current accrued taxes	2,453
Funding of qualified pension plans	(12,498)
Change in restricted cash, net	4,160
Other, net	3,734
Net cash (used in) provided by operating activities	(18,088)
CASH FLOWS FROM INVESTING ACTIVITIES
Change in short-term investments, net	71,094
Additions to plant and equipment	(117,525)
Proceeds from sale of assets	12,826
Net cash used for investing activities	(33,605)
CASH FLOWS FROM FINANCING ACTIVITIES
Deferred loan fees	(638)
Purchase of treasury stock	(11,350)
Excess tax benefits from equity-based payment arrangements	885
Payment of employee restricted stock tax withholdings	(2,400)
Investment from (to) Parent	51,621
Other, net	2
Net cash (used for) provided by financing activities	38,120
(Decrease) increase in cash	(13,573)
Cash at beginning of period	15,719
Cash at end of period	2,146
Guarantor Subsidiaries
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	4,038
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	25,956
Deferred tax expense (benefit)	5,473
Change in working capital, net	23,959
Change in taxes receivable, net	1,939
Other, net	672
Net cash (used in) provided by operating activities	62,037
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to plant and equipment	(15,654)
Net cash used for investing activities	(15,654)
CASH FLOWS FROM FINANCING ACTIVITIES
Investment from (to) Parent	(47,210)
Net cash (used for) provided by financing activities	(47,210)
(Decrease) increase in cash	(827)
Cash at beginning of period	1,728
Cash at end of period	901
Non-Guarantor Subsidiaries
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	2,061
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	5,538
Deferred tax expense (benefit)	2,040
Change in working capital, net	23,171
Change in taxes receivable, net	(217)
Other, net	2
Net cash (used in) provided by operating activities	32,595
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to plant and equipment	(890)
Net cash used for investing activities	(890)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of Cellu Tissue debt	(15,595)
Investment from (to) Parent	(12,560)
Net cash (used for) provided by financing activities	(28,155)
Effect of exchange rate changes	361
(Decrease) increase in cash	3,911
Cash at beginning of period	1,481
Cash at end of period	5,392
Eliminations
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	(8,149)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Net cash (used in) provided by operating activities	(8,149)
CASH FLOWS FROM FINANCING ACTIVITIES
Investment from (to) Parent	8,149
Net cash (used for) provided by financing activities	$ 8,149

Name:	us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).